Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06600126 · ClinicalTrials.gov registry record · NA

Supporting Evidence-based Responses to Emotional Needs in Emphysema

A NA study of COPD, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
750
Enrollment target
2
Study locations

NCT06600126: Recruiting NA study of COPD, sponsored by University of Pennsylvania.

NCT06600126 is a NA study of COPD that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 750 participants, below the 2,410-participant average among 85 other COPD trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06600126, a NA study of COPD, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
750 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to understand how a Coping Skills Training program can reduce depression and anxiety in people with chronic obstructive pulmonary disease (COPD), particularly those who face health disparities, including those with low income, different racial backgrounds, or those living in rural areas. The main questions it aims to answer are: * How does the Coping Skills Training program help reduce stress and anxiety in patients? * What causes variations in the effectiveness of the Coping Skills Training program? * What are the barriers and facilitators to the uptake of the Coping Skills Training program? Researchers will compare a 12-week Coping Skills Training program with a COPD Education program to see if the training leads to better health outcomes for participants. Participants will: * Take part in weekly 30-minute sessions for 12 weeks if assigned to the Coping Skills Training group. * Take part in weekly 10-minute sessions for 12 weeks if assigned to the COPD Education group. * Complete surveys before, during, and after the intervention. * Patients and caregivers, including those who chose not to enroll, as well as clinicians, will be invited to participate in interviews to share their perspectives.

Primary Outcome

Patient psychological distress will be measured using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 consists of 9 items, with total scores ranging from 0 to 27. Higher scores indicate greater distress.

Conditions Studied

Interventions

  • BEHAVIORAL COPD Education
  • BEHAVIORAL Coping Skills Training

Study Locations (2)

Michigan

  • Henry Ford Health System - Detroit

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2024-09-30
Est. Completion 2028-03-05
Phase NA
University of Pennsylvania

1,423 total trials

What NCT06600126 shows while recruiting

NCT06600126 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 2,410-participant average among 85 other COPD trials with a reported enrollment target (69% lower).

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which COPD Education is the first listed.

NCT06600126 reports a single indexed study location in Michigan, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06600126 about?

NCT06600126 is a clinical study titled "Supporting Evidence-based Responses to Emotional Needs in Emphysema". The goal of this clinical trial is to understand how a Coping Skills Training program can reduce depression and anxiety in people with chronic obstructive pulmonary disease (COPD), particularly those who face health disparities, including those with low income, different racial backgrounds, or those...

What is the current status of trial NCT06600126?

This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2024-09-30. Estimated completion is 2028-03-05.

What conditions does trial NCT06600126 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT06600126?

The interventions under investigation include: COPD Education (BEHAVIORAL), Coping Skills Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06600126?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06600126 being conducted?

This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06600126's enrollment target sits among peer trials

750 12th of 85 higher than 74 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06600126, the US trial registry maintained by the National Library of Medicine. NCT06600126 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.